Yoyo dieting alters gut health, driving weight regain and inflammation

Researchers from Deakin University reveal how yoyo dieting disrupts gut health, leading to weight regain and obesity-related complications. The study highlights the roles of gut microbiota, hormones, and inflammation in the weight cycling process.

FDA advises clinicians to stop using Hologic radiographic markers

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration

October 28, 2024

Genmab AS Patent Filing for Diffuse Large B-Cell Lymphoma Treatment

Share this article According to GlobalData’s company profile on Genmab, Personalized cancer vaccines was a key innovation area identified from patents. Genmab‘s grant share as

March 26, 2024

FDA rejects Zealand Pharma’s short bowel syndrome drug

The FDA rejected Zealand Pharma’s short bowel syndrome drug, and asked the company to run another trial before it reconsiders. The FDA told Zealand it

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.